Expression and secretion of functional miniantibodies McPC603scFvDhlx in cell-wall-less L-form strains of Proteus mirabilis and Escherichia coli: A comparison of the synthesis capacities of L-form strains with an E. coli producer strain

Applied Microbiology and Biotechnology

Volumn 49, Issue 1, 1998, Pages 51-58

  Kujau, M J ^a   Hoischen, C ^b   Riesenberg, D ^a   Gumpert, J ^b  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA; ESCHERICHIA COLI; MOLECULAR CLONING; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN SECRETION; PROTEUS MIRABILIS;

ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ESCHERICHIA COLI; L FORMS; PROTEUS MIRABILIS; RECOMBINANT PROTEINS; TRANSFORMATION, BACTERIAL;

ESCHERICHIA COLI; MIRABILIS; NEGIBACTERIA; PROTEUS MIRABILIS;

EID: 0031973556     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002530051136     Document Type: Article

References (34)

1. Bardwell J (1994) Building bridges: disulphide bond formation in the cell. Mol Microbiol 14: 199-205
2. Böck A, Wirth R, Schmid G, Schumacher G, Lang G, Buckel P (1983) The penicillin acylase from Escherichia coli ATCC 11105 consists of two dissimilar subunits. FEMS Microbiol Lett 20: 135-139
3. Bruns W, Hoppe J, Tsai H, Brünning HJ, Maywald F, Collins J, Mayer H (1985) Structure of the penicillin acylase gene from Escherichia coli: a periplasmic enzyme that undergoes multiple proteolytic processing. J Molec Appl Genetics 3: 36-44
4. Carter P, Kelley RF, Rodrigues ML, Snedecor B, Covarrubias M, Velligan MD, Wong WLT, Roland AM, Kotts CE, Carver ME, Yang M, Bourell JH, Shepard M, Henner D (1992) High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Bio technology 10: 163-167
5. Ge L, Knappik A, Pack P, Freund C, Plückthun A (1995) Expressing antibodies in Escherichia coli. In: C.A. Borrebeck (ed) Antibody engineering. Oxford University Press, New York Oxford, pp 229-266
6. Glockshuber R, Malia M, Pfitzinger I, Plückthun A (1990) A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29: 1362-1367
7. Gumpert J, Taubeneck U (1983) Characteristic properties and biological significance of stable protoplast type L-forms. Experientia Suppl 46: 227-241
8. Gumpert J, Schuhmann E, Taubeneck U (1971) Ultrastruktur der stabilen L-Formen von Escherichia coli B und W1655 F+. Z Allg Mikrobiol 11: 19-33
9. Gumpert J, Cron H, Plapp R, Niersbach H, Hoischen C (1996) Synthesis and secretion of recombinant penicillin G acylase in bacterial L-forms. J Basic Microbiol 36: 89-98
10. Horn U, Strittmatter W, Krebber A, Knüpfer U, Kujau M, Wenderoth R, Müller K, Matzku S, Plückthun A, Riesenberg D (1996) High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. Appl Microbiol Biotechnol 46: 524-532
11. Klessen CH, Schmidt KH, Gumpert J, Grosse HH, Malke H (1988) Complete secretion of activable bovine prochymosin by genetically engineered L-forms of Proteus mirabilis. Appl Environm Microbiol 55: 1009-1015
12. Knappik A, Plückthun A (1994) An improved Tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. Biotechniques 17: 754-761
13. Knappik A, Krepper C, Plückthun A (1993) The effect of folding catalysts on the in vivo folding process of different antibody fragments expressed in Escherichia coli. Biotechnology 11: 77-83
14. Korz DJ, Rinas U, Hellmuth K, Sanders EA, Deckwer WD (1995) Simple fed-batch technique for high cell density cultivation of Escherichia coli. J Biotechnol 39: 59-65
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227: 680-685
16. Laplace F, Müller J, Gumpert J, Malke H (1989a) Novel shuttle vector for improved streptokinase expression in streptococci and bacterial L-forms. FEMS Microbiol Lett 65: 89-94
17. Laplace F, Egerer R, Gumpert J, Kraft R, Kostka S, Malke H (1989b) Heterologous signal peptide processing in fusion interferon synthesis by engineered L-forms of Proteus mirabilis. FEMS Microbiol Lett 59: 59-64
18. Löser C (1990) Stabilitätsverhalten eines rekombinanten ColE1-Plasmidderivates mit Ampicillin-Resistenzmarker und HumanInterferon-α-1-gen in Escherichia coli. PhD Thesis. Technical University Dresden, Germany
19. R 3 and autogenous negative control by repressor. J Mol Biol 139: 147-161
20. Narciandi RE, Mörbe FJ, Riesenberg D (1996) Maximizing the expression of recombinant kringle 1 streptokinase synthesized in Escherichia coli. Influence of culture and induction conditions. Biotechnol Lett 18: 1261-1266
21. Pack P, Kujau M, Schroeckh V, Knüpfer U, Wenderoth R, Riesenberg D, Plückthun A (1993) Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Biotechnology 11: 1271-1277
22. Pack P, Müller K, Zahn R, Plückthun A (1995) Tetravalent miniantibodies with high avidity assembling in Escherichia coli. J Mol Biol 246: 28-34
23. Pan JG, Rhee JS, Lebeault JM (1987) Physiological constrains in increasing biomass concentration of Escherichia coli in fedbatch culture. Biotechnol Lett 2: 89-94
24. Plückthun A (1994a) Antibodies from Escherichia coli. In: Rosenberg M, Moore GP (eds) Handbook of experimental pharmacology, vol 113. Springer, Berlin Heidelberg New York, pp 269-315
25. Plückthun A (1994b) Recombinant antibodies. In: Oss CJ van, Regenmortel MHV van (eds) Immunochemistry. Decker, Basel New York, pp 201-315
26. Plückthun A, Krebber A, Krebber C, Horn U, Knüpfer U, Wenderoth R, Nieba L, Proba K, Riesenberg D (1996) Producing antibodies in Escherichia coli: from PCR to fermentation. In: McCafferty J, Hoogenboom HR, Chiswells DJ (eds) Antibody engineering. A practical approach. IRL, Oxford, pp 203-252
27. Riesenberg D (1991) High-cell-density cultivation of Escherichia coli. Curr Opin Biotechnol 2: 380-384
28. Riesenberg D, Knüpfer U, Kujau M, Schroeckh V, Wenderoth R (1995) A method for cultivation of Escherichia coli to very high biomass concentrations for studies of cell-density dependent expression systems. In: Europ. Feder. Biotechnology (ed) Microbial physiology conference book, transport, signalling and its metabolic consequences in microorganisms, druk acco Leuven p 48
29. Rinas U, Kracke-Helm HA, Schügerl (1989) Glucose as a substrate in the fermentation technology. Appl Microbiol Biotechnol 32: 163-167
30. Schroeckh V, Kujau M, Knüpfer U, Wenderoth R, Mörbe J, Riesenberg D (1996) Formation of recombinant proteins in Escherichia coli under control of a nitrogen regulated promoter at low and high cell densities. J Biotechnol 49: 45-58
31. Schumacher G, Sizmann D, Haug H, Buckel P, Böck A (1986) Penicillin acylase from E. coli: unique gene-protein relation. Nucleic Acids Res 14: 5713-5728
32. Skerra A, Plückthun A (1988) Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240: 1038-1041
33. Strandberg L, Andersson L, Enfors SO (1994) The use of fed batch cultivation for achieving high cell densities in the production of a recombinant protein in Escherichia coli. FEMS Microbiol Rev 14: 53-56
34. Wülfing C, Plückthun A (1994) Correctly folded T-cell receptor fragments in the periplasm of Escherichia coli. Influence of folding catalysts. J Mol Biol 242: 655-669